Bethesda, Maryland-based medical technology developer New Health Sciences has received a three-year, $3 million grant from a National Institutes of Health organization to develop and test anaerobic storage technology for donated blood.
The company said Wednesday it aims to commercialize the gas-optimized Hemanext storage system, designed to help preserve the quality of red blood cells during prolonged storage.
“We are proud and fortunate to have the continued support of the NIH in our mission to improve the safety and efficacy of transfusion therapy,“ noted Martin Cannon, CEO of New Health Sciences.
NHSi intends for its technology to minimize the degradation of donated red blood cells and enhance their metabolism in order to facilitate blood transfusion methods.
NIH’s National Heart Lung and Blood Institute awarded the funds to New Health Sciences under the agency’s Small Business Innovation Research Phase IIB Bridge Grant program.